［1］BRAY F,FERLAY J,SOERJOMATARAMAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2018,68(6):394-424.
［2］CHEN W,ZHENG R,BAADA PD,et al.Cancer statistics in China,2015［J］.CA Cancer J Clin,2016,66(2):115-132.
［3］GUO C,WEI J,SCOTT RS,et al.Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province,Northwest China with mRNA expression of glycoprotein BMRF2［J］.J Med Virol,2020,92(3):356-363.
［4］SAWAKI K,KANDA M,KODERA Y.Review of recent efforts to discover biomarkers for early detection,monitoring,prognosis,and prediction of treatment responses of patients with gastric cancer［J］.Expert Rev Gastroenterol Hepatol,2018,12(7):657-670.
［5］SONG YX,HUAND XZ,GAO P,et al.Clinicopathologic and prognostic value of serum carbohydrate antigen 19-9 in gastric cancer:A Meta-analysis［J］.Dis Markers,2015,549843:1-11.
［6］杨京彦.MCM7在胃癌组织中的表达及对胃癌细胞增殖、侵袭和转移的影响及机制［D］.济南：山东大学,2019.
YANG JY.Expression of MCM7 and its effect and mechanism on proliferation,invasion and metastasis of gastric cancer［D］.Jinan:Shandong University,2019.
［7］冉冰冰,梁楠,孙辉.基于质谱的高通量蛋白质组学技术探索肿瘤蛋白标志物的研究进展［J］.中国肿瘤临床,2020,47(08):411-417.
RAN BB,LIANG N,SUN H.Research progress on tumor protein biomarkers using high-throughput proteomics based on mass spectrometry ［J］.Chin J Clin Oncol,2020,47(08):411-417.
［8］BABU N,BHAT MY,JOHN AE,et al.The role of proteomics in the multiplexed analysis of gene alterations in human cancer［J］.Expert Rev Proteomics,2021,18(9):737-756.
［9］KANG C,LEE Y,LEE JE.Recent advances in mass spectrometry-based proteomics of gastric cancer［J］.World J Gastroenterol,2016,22(37):8283-8293.
［10］PAGEL O,KOLLIPARA L,SICKMANN A.Tandem mass tags for comparative and discovery proteomics［J］.Methods Mol Biol,2021,2228:117-131.
［11］YU D,WANG Z,CUPP-SUTTON KA,et al.Quantitative top-down proteomics in complex samples using protein-level tandem mass tag labeling［J］.J Am Soc Mass Spectrom,2021,32(6):1336-1344.
［12］YANG Z,YAN C,LIU W,et al.Identification of novel autoantibodies in ascites of relapsed paclitaxel-resistant gastric cancer with peritoneal metastasis using immunome protein microarrays and proteomics［J］.Cancer Biomark,2021,31(4):329-338.
［13］ABE Y,HIRANO H,SHOJI H,et al.Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens［J］.Theranostics,2020,10(5):2115-2129.
［14］李廷跃,吴帆.高内涵筛选在分子机制研究中的应用［J］.实用医学杂志,2018,34(02):328-330.
LI TY,WU F.Application of high-content screening in molecular mechanism research［J］.The Journal of Practical Medicine,2018,34(02):328-330.
［15］GU J,HU X,SHAO W,et al.Metabolomic analysis reveals altered metabolic pathways in a rat model of gastric carcinogenesis［J］.Oncotarget,2016,7(37):60053-60073.
［16］BALAKRISHNAN K,GANESAN K.Occurrence of differing metabolic dysregulations,a glucose driven and another fatty acid centric in gastric cancer subtypes［J］.Funct Integr Genomics,2020,20(6):813-824.
［17］MOMMERSTEEG MC,SIMOVIC I,YU B,et al.Autophagy mediates ER stress and inflammation in Helicobacter pylori-related gastric cancer［J］.Gut Microbes,2022,14(1):2015238.
［18］FENG H,JIN Z,LIU K,et al.Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression［J］.J Cell Mol Med,2020,24(21):12667-12680.
［19］WANF YY,LI L,ZHAO ZS,et al.L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients［J］.J Exp Clin Cancer Res,2013,32(1):1-11.
［20］YANG X,CHEN L,MAO Y,et al.Progressive and prognostic performance of an extracellular matrix-receptor interaction signature in gastric cancer［J］.Dis Markers,2020,8816070:1-23.
［21］RAFTERY TD,ISALES GM,YOZZO KL,et al.High-content screening assay for identification of chemicals impacting spontaneous activity in ebrafish embryos［J］.Environ Sci Technol,2014,48(1):804-810.
［22］郭萍,陈丽萍,陈雯.高内涵筛选技术在毒理学研究中的应用进展［J］.中华预防医学杂志,2022,56(01):15-19.
GUO P,CHEN L,CHEN W.Advances in high content screening applications in toxications research［J］.January of Chin J Prev Med,2022,56(01):15-19.
［23］XIONG F,LI S.SF3b4:A versatile player in eukaryotic cells［J］.Front Cell Dev Biol,2020,3(8):14.
［24］GOLAS MM,SANDER B,WILL CL,et al.Molecular architecture of the multiprotein splicing factor SF3b［J］.Science,2003,300 (5621):980-984.
［25］DIAO Y,LI Y,WANG Z,et al.SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52［J］.Cell Death Dis,2022,13(2):179.
［26］BEMIER FP,CALUSERIU O,NG S,et al.Haploinsufficiency of SF3B4,a component of the pre-mRNA spliceosomal complex,causes Nager syndrome［J］.Am J Hum Genet,2012,90(5):925-933.
［27］WATANABE H,SHIONYU M,KIMURA T,et al.Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteochondral cell differentiation［J］.J Biol Chem,2007,282(28):20728-20738.
［28］TERADA Y,YASUDA Y.Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145［J］.Mol Cell Biol,2006,26(21):8149-8158.
［29］KIDOGAMI S,IGUCHI T,SATO K,et al.SF3B4 plays an oncogenic role in esophageal squamous cell carcinoma［J］.Anticancer Res,2020,40(5):2941-2946.
［30］CASSINA M,CERQUA C,ROSSI S,et al.A synonymous splicing mutation in the SF3B4 gene segregates in a family with highly variable Nager syndrome［J］.Eur J Hum Genet,2017,25(3):371-375.
［31］KIM H,LEE J,JUNG SY,et al.SF3B4 depletion retards the growth of A549 non-small cell lung cancer cells via UBE4B-mediated regulation of p53/p21 and p27 Expression［J］.Mol Cells,2022,45(10):718-728.
［32］LI Y,DIAO Y,WANG Z,et al.The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5［J］.Cell Death Discov,2022,8(1):326.
［33］LIU Z,LI W,PANG Y,et al.SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma［J］.EBioMedicine,2018,38:57-68.
［34］ZHOU W,MA N,JIANG H,et al.SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells［J］.Tumour Biology,2017,39(3):1010428317695913.